IMR Press / RCM / Volume 23 / Issue 4 / DOI: 10.31083/j.rcm2304116
Open Access Review
Transcatheter mitral valve repair for primary mitral regurgitation
Show Less
1 Department of Cardiology, Houston Methodist DeBakey Heart & Vascular Center, Houston, TX 77030, USA
*Correspondence: nnfaza@houstonmethodist.org (Nadeen N. Faza)
Academic Editors: Christos Mihos, Francesco Nappi, Cristiano Spadaccio and Massimo Chello
Rev. Cardiovasc. Med. 2022, 23(4), 116; https://doi.org/10.31083/j.rcm2304116
Submitted: 15 November 2021 | Revised: 27 December 2021 | Accepted: 30 December 2021 | Published: 26 March 2022
(This article belongs to the Special Issue The treatment of mitral regurgitation in the 21st Century)
Copyright: © 2022 The Author(s). Published by IMR Press.
This is an open access article under the CC BY 4.0 license.
Abstract

The landscape of transcatheter mitral valve repair devices continues to expand, with many technologies undergoing investigation in patients with primary mitral regurgitation (MR). Transcatheter edge-to-edge repair (TEER) of the mitral valve is currently approved for management of patients with severe primary MR who are deemed to be high risk surgical candidates. The current review will focus on an integrative clinical and echocardiographic approach to guide patient selection, intra-procedural imaging guidance, and post procedural follow up in patients undergoing TEER. This review will also highlight future directions in transcatheter repair techniques of the mitral valve.

Keywords
mitral regurgitation
mitraClip
transcatheter mitral valve repair
Figures
Fig. 1.
Share
Back to top